Stryker’s Trauma & Extremities division has launched its Citrelock™ Tendon Fixation Device System. Citrelock provides a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen™, that has unique chemical and mechanical properties for orthopedic surgical applications.
Citrelock Tendon Fixation Device System offers:
- A controlled and homogeneous resorption process that prevents bulk degradation and chronic inflammation.
- Compressive strength that is comparable to cortical bone with a modulus comparable to cancellous bone.
- Citregen contains citrate, calcium and phosphate molecules that are inherent to the bone anatomy.
- Material polymer structure that mimics the extracellular matrix protein network.
Citregen maintains structural integrity during the healing phase, while the implant is replaced by host tissue over time.